U.S. flag

An official website of the United States government

NM_000277.3(PAH):c.284_285delinsCA (p.Ile95Thr) AND Phenylketonuria

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Jan 25, 2020
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000106353.5

Allele description [Variation Report for NM_000277.3(PAH):c.284_285delinsCA (p.Ile95Thr)]

NM_000277.3(PAH):c.284_285delinsCA (p.Ile95Thr)

Gene:
PAH:phenylalanine hydroxylase [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
12q23.2
Genomic location:
Preferred name:
NM_000277.3(PAH):c.284_285delinsCA (p.Ile95Thr)
HGVS:
  • NC_000012.12:g.102894802_102894803delinsTG
  • NG_008690.2:g.68608_68609delinsCA
  • NM_000277.3:c.284_285delinsCAMANE SELECT
  • NM_001354304.2:c.284_285delinsCA
  • NP_000268.1:p.Ile95Thr
  • NP_001341233.1:p.Ile95Thr
  • NC_000012.11:g.103288580_103288581delinsTG
  • NC_000012.12:g.102894802_102894803delGAinsTG
  • NM_000277.1:c.284_285delTCinsCA
  • NM_000277.1:c.284_285delinsCA
  • NM_000277.2(PAH):c.284_285delTCinsCA
  • p.Ile95Thr
Protein change:
I95T
Links:
dbSNP: rs281865432
NCBI 1000 Genomes Browser:
rs281865432
Molecular consequence:
  • NM_000277.3:c.284_285delinsCA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354304.2:c.284_285delinsCA - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Phenylketonuria (PKU)
Synonyms:
Phenylketonurias; Oligophrenia phenylpyruvica; Folling disease
Identifiers:
MONDO: MONDO:0009861; MedGen: C0031485; Orphanet: 716; OMIM: 261600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000143852Inserm U 954, Faculté de Médecine de Nancy
no assertion criteria provided
probable-pathogenicunknownnot provided

SCV001250558ClinGen PAH Variant Curation Expert Panel
reviewed by expert panel

(ClinGen PAH ACMG Specifications v1)
Uncertain significance
(Jan 25, 2020)
germlinecuration

Citation Link,

SCV001374395Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 4, 2019)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation
not providednot providednot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Mutation spectrum in Taiwanese patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutation.

Chien YH, Chiang SC, Huang A, Chou SP, Tseng SS, Huang YT, Hwu WL.

Hum Mutat. 2004 Feb;23(2):206. doi: 10.1002/humu.9215.

PubMed [citation]
PMID:
14722928

Mutational spectrum of phenylketonuria in Jiangsu province.

Chen YF, Jia HT, Chen ZH, Song JP, Liang Y, Pei JJ, Wu ZJ, Wang J, Qiu YL, Liu G, Sun DM, Jiang XY.

Eur J Pediatr. 2015 Oct;174(10):1333-8. doi: 10.1007/s00431-015-2539-z. Epub 2015 Apr 19.

PubMed [citation]
PMID:
25894915
See all PubMed Citations (9)

Details of each submission

From Inserm U 954, Faculté de Médecine de Nancy, SCV000143852.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot providednot provided

Description

Converted during submission to Likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

From ClinGen PAH Variant Curation Expert Panel, SCV001250558.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.284_285delTCinsCA (p.Ile95Thr) indel variant in PAH has not been reported in the literature to our knowledge. It has been included in BioPKU/PAHdb (PAH0793) by online submission (Namour et al.,2013). It is absent from ExAC, gnomAD, 1000G, and ESP. There is not consensus among predictions of pathogenicity. In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001374395.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

This sequence change replaces isoleucine with threonine at codon 95 of the PAH protein (p.Ile95Thr). The isoleucine residue is highly conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PAH-related conditions. ClinVar contains an entry for this variant (Variation ID: 120272). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). This variant disrupts the p.Ile95 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14722928, 1709636, 17096675, 18985011, 19292873, 23430918, 25894915, 26666653). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024